{"id":45989,"date":"2022-07-08T18:01:32","date_gmt":"2022-07-08T16:01:32","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/median-technologies-to-participate-in-the-2022-european-congress-of-radiology-ecr-july-13-17-2022-vienna-austria-with-two-presentations-on-ibiopsy\/"},"modified":"2022-07-08T18:01:32","modified_gmt":"2022-07-08T16:01:32","slug":"median-technologies-to-participate-in-the-2022-european-congress-of-radiology-ecr-july-13-17-2022-vienna-austria-with-two-presentations-on-ibiopsy","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/median-technologies-to-participate-in-the-2022-european-congress-of-radiology-ecr-july-13-17-2022-vienna-austria-with-two-presentations-on-ibiopsy\/","title":{"rendered":"Median Technologies to Participate in the 2022 European Congress of Radiology (ECR), July 13 \u2013 17, 2022, Vienna, Austria, with Two Presentations on iBiopsy\u00ae"},"content":{"rendered":"<div>\n<ul class=\"bwlistdisc\">\n<li>\nIndustry presentation on July 13, 2022: \u201cEnabling lung cancer screening with iBiopsy\u00ae AI-based software as medical device\u201d\n<\/li>\n<li>\nScientific paper presentation on July 15, 2022: \u201cDevelopment and validation of a machine learning based CADx designed to improve patient management in lung cancer screening programmes\u201d\n<\/li>\n<li>\nMedian will present the latest developments on iBiopsy\u00ae LCS CADe\/CADx<sup>1<\/sup> Software as Medical Device (SaMD) at Booth #AI-29, Expo X1, AI-area\n<\/li>\n<\/ul>\n<p>SOPHIA ANTIPOLIS, France&#8211;(BUSINESS WIRE)&#8211;Regulatory News:\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220708005258\/en\/1343975\/5\/Median_RGB.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220708005258\/en\/1343975\/21\/Median_RGB.jpg\"><\/a><\/p>\n<p>\nMedian Technologies (ALMDT) (Paris:ALMDT) announced today that the Company will be participating in the 2022 European Congress of Radiology (ECR), to be held in Vienna, Austria, July 13-17.\n<\/p>\n<p>\nThe Company will give an industry presentation and a scientific paper presentation. Details of the sessions include:\n<\/p>\n<p>\n<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fconnect.myesr.org%2Fecr-2022%2Fecr-2022-programme%2F%3Ftabref%3D1&amp;esheet=52775045&amp;newsitemid=20220708005258&amp;lan=en-US&amp;anchor=Industry+presentation%3A&amp;index=1&amp;md5=5f36c0811fee30b27170edc11c7f6c29\" rel=\"nofollow noopener\" shape=\"rect\"><b>Industry presentation:<\/b><\/a><b> \u201c<\/b>Enabling lung cancer screening with iBiopsy\u00ae AI-based software as medical device\u201d\n<\/p>\n<p class=\"bwmarginl1\">\nSession: AIX Theater<br \/>\n<br \/>Date: July 13, 2022<br \/>\n<br \/>Time: 3:25 pm \u2013 3:45 pm CEST\n<\/p>\n<p>\n<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fconnect.myesr.org%2Fecr-2022%2Fecr-2022-programme%2F%3F&amp;esheet=52775045&amp;newsitemid=20220708005258&amp;lan=en-US&amp;anchor=Scientific+paper+presentation&amp;index=2&amp;md5=05a40293d11bc11da8fe0f680525e4f5\" rel=\"nofollow noopener\" shape=\"rect\"><b>Scientific paper presentation<\/b><\/a><b>: <\/b>RPS 1305-6 \u2013 \u201cDevelopment and validation of a machine learning based CADx designed to improve patient management in lung cancer screening programmes\u201d\n<\/p>\n<p class=\"bwmarginl1\">\nSession: RPS 1305 &#8211; Artificial intelligence (AI) in chest imaging: part 2<br \/>\n<br \/>Categories: Artificial Intelligence &amp; Machine Learning, Imaging Informatics, Chest, Oncologic Imaging<br \/>\n<br \/>Date: July 15, 2022<br \/>\n<br \/>Time: 10:30 am &#8211; 12:00 pm CEST\n<\/p>\n<p>\nMedian\u2019s team will be available at booth #AI-29, Expo X1, AI-area to discuss the presentations and present the latest developments on iBiopsy\u00ae LCS CADe\/CADx SaMD from July 13 to 17, 9:00 am-5:00 pm.\n<\/p>\n<p>\nThe European Congress of Radiology (ECR) organized by the European Society of Radiology (ESR) is the premier European event in radiology and the second largest in the world. The congress conveys more than 20,000 with a split of more than 10,000 professional delegates (radiologists, technologists etc.), and ~8,000 industry participants (imaging modalities, PACS etc.). Radiology professionals from Europe and beyond attend to gather knowledge through educational courses, to see the latest innovations presented by technical exhibitors, and to discover groundbreaking research from scientific paper presentations. More about the ECR: <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.myesr.org%2Fcongress&amp;esheet=52775045&amp;newsitemid=20220708005258&amp;lan=en-US&amp;anchor=https%3A%2F%2Fwww.myesr.org%2Fcongress&amp;index=3&amp;md5=dec3345a5166391d1b186edf7b220b3b\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.myesr.org\/congress<\/a>\n<\/p>\n<p>\n<b>About iBiopsy\u00ae:<\/b> iBiopsy\u00ae is based on the most advanced technologies in Artificial Intelligence (AI) and Data Science (DS), benefiting from Median\u2019s expertise in medical image processing. iBiopsy\u00ae targets the development of innovative AI\/ML-based Software as Medical Device, to be used in several indications for which there are unmet needs regarding early diagnosis, prognosis and treatment selection in the context of precision medicine. iBiopsy\u00ae currently focuses on lung cancer, liver cancer (HCC) and liver fibrosis (NASH).\n<\/p>\n<p>\n<strong>About Median Technologies:<\/strong><b> <\/b>Median Technologies provides innovative imaging solutions and services to advance healthcare for everyone. We harness the power of medical images by using the most advanced Artificial Intelligence technologies, to increase the accuracy of diagnosis and treatment of many cancers and other metabolic diseases at their earliest stages and provide insights into novel therapies for patients. Our iCRO solutions for medical image analysis and management in oncology trials and iBiopsy\u00ae, our AI-powered software as medical device help biopharmaceutical companies and clinicians to bring new treatments and diagnose patients earlier and more accurately. This is how we are helping to create a healthier world.\n<\/p>\n<p>\nFounded in 2002, based in Sophia-Antipolis, France, with a subsidiary in the US and another one in Shanghai, Median has received the label \u201cInnovative company\u201d by the BPI and is listed on Euronext Growth market (Paris). FR0011049824\u2013 ticker: ALMDT. Median is eligible for the French SME equity savings plan scheme (PEA-PME), is part of the Enternext\u00ae PEA-PME 150 index and has been awarded the Euronext European Rising Tech label. For more information: <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.mediantechnologies.com%2F&amp;esheet=52775045&amp;newsitemid=20220708005258&amp;lan=en-US&amp;anchor=www.mediantechnologies.com&amp;index=4&amp;md5=05367a944d4690d63b87428f969c524c\" rel=\"nofollow noopener\" shape=\"rect\">www.mediantechnologies.com<\/a>\n<\/p>\n<p>\n<sup>1<\/sup> A radiological CADe device is <i>\u201cintended to identify, mark, highlight or otherwise direct attention to portions of an image that may reveal abnormalities during interpretation of images by the clinician<\/i>.\u201d A CADx device is \u201c<i>intended to provide information beyond identifying abnormalities, such as an assessment of disease.\u201d Source: FDA<\/i>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\n<b>Median Technologies<\/b><br \/>Emmanuelle Leygues<br \/>\n<br \/>Head of Corporate Marketing &amp; Financial Communications<br \/>\n<br \/>+33 6 10 93 58 88<br \/>\n<br \/><a target=\"_blank\" href=\"m&#97;&#x69;&#x6c;&#x74;o&#58;&#101;&#x6d;&#x6d;a&#110;&#117;&#x65;&#x6c;le&#46;&#x6c;&#x65;&#x79;g&#117;&#x65;&#x73;&#x40;m&#101;&#100;&#x69;&#x61;n&#116;&#101;&#x63;&#x68;no&#108;&#x6f;&#x67;&#x69;e&#115;&#46;&#x63;&#x6f;m\" rel=\"nofollow noopener\" shape=\"rect\">&#101;&#x6d;m&#x61;&#x6e;&#117;&#x65;l&#108;&#x65;&#46;&#x6c;e&#121;&#x67;u&#x65;s&#64;&#x6d;e&#x64;&#x69;&#97;&#x6e;t&#101;&#x63;&#104;&#x6e;o&#108;&#x6f;&#103;&#x69;e&#115;&#x2e;c&#x6f;&#x6d;<\/a>\n<\/p>\n<p>\n<b>Press &#8211; ALIZE RP<\/b><br \/>Caroline Carmagnol<br \/>\n<br \/>+33 6 64 18 99 59<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#x61;i&#108;&#x74;o&#58;&#x6d;e&#100;&#x69;a&#110;&#x40;a&#108;&#x69;z&#101;&#x72;p&#46;&#x63;o&#109;\" rel=\"nofollow noopener\" shape=\"rect\">med&#105;&#97;&#110;&#64;&#x61;&#x6c;&#x69;&#x7a;&#x65;&#x72;&#x70;&#46;co&#109;<\/a>\n<\/p>\n<p>\n<b>Investors &#8211; ACTIFIN<\/b><br \/>Ghislaine Gasparetto<br \/>\n<br \/>+33 6 21 10 49 24<br \/>\n<br \/><a target=\"_blank\" href=\"m&#97;&#x69;&#x6c;t&#111;&#58;&#x67;&#x67;a&#115;&#x70;&#x61;r&#101;&#116;&#x74;&#x6f;&#64;&#97;&#x63;&#x74;i&#102;&#105;&#x6e;&#x2e;f&#114;\" rel=\"nofollow noopener\" shape=\"rect\">&#x67;&#x67;&#x61;&#x73;&#112;&#97;&#114;&#101;tto&#x40;&#x61;&#x63;&#x74;&#x69;&#102;&#105;&#110;&#46;fr<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Industry presentation on July 13, 2022: \u201cEnabling lung cancer screening with iBiopsy\u00ae AI-based software as medical device\u201d Scientific paper presentation on July 15, 2022: \u201cDevelopment and validation of a machine learning based CADx designed to improve patient management in lung cancer screening programmes\u201d Median will present the latest developments on iBiopsy\u00ae LCS CADe\/CADx1 Software as &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/median-technologies-to-participate-in-the-2022-european-congress-of-radiology-ecr-july-13-17-2022-vienna-austria-with-two-presentations-on-ibiopsy\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-45989","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Median Technologies to Participate in the 2022 European Congress of Radiology (ECR), July 13 \u2013 17, 2022, Vienna, Austria, with Two Presentations on iBiopsy\u00ae - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/median-technologies-to-participate-in-the-2022-european-congress-of-radiology-ecr-july-13-17-2022-vienna-austria-with-two-presentations-on-ibiopsy\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Median Technologies to Participate in the 2022 European Congress of Radiology (ECR), July 13 \u2013 17, 2022, Vienna, Austria, with Two Presentations on iBiopsy\u00ae - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Industry presentation on July 13, 2022: \u201cEnabling lung cancer screening with iBiopsy\u00ae AI-based software as medical device\u201d Scientific paper presentation on July 15, 2022: \u201cDevelopment and validation of a machine learning based CADx designed to improve patient management in lung cancer screening programmes\u201d Median will present the latest developments on iBiopsy\u00ae LCS CADe\/CADx1 Software as ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/median-technologies-to-participate-in-the-2022-european-congress-of-radiology-ecr-july-13-17-2022-vienna-austria-with-two-presentations-on-ibiopsy\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-07-08T16:01:32+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220708005258\/en\/1343975\/21\/Median_RGB.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/median-technologies-to-participate-in-the-2022-european-congress-of-radiology-ecr-july-13-17-2022-vienna-austria-with-two-presentations-on-ibiopsy\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/median-technologies-to-participate-in-the-2022-european-congress-of-radiology-ecr-july-13-17-2022-vienna-austria-with-two-presentations-on-ibiopsy\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Median Technologies to Participate in the 2022 European Congress of Radiology (ECR), July 13 \u2013 17, 2022, Vienna, Austria, with Two Presentations on iBiopsy\u00ae\",\"datePublished\":\"2022-07-08T16:01:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/median-technologies-to-participate-in-the-2022-european-congress-of-radiology-ecr-july-13-17-2022-vienna-austria-with-two-presentations-on-ibiopsy\\\/\"},\"wordCount\":666,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/median-technologies-to-participate-in-the-2022-european-congress-of-radiology-ecr-july-13-17-2022-vienna-austria-with-two-presentations-on-ibiopsy\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220708005258\\\/en\\\/1343975\\\/21\\\/Median_RGB.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/median-technologies-to-participate-in-the-2022-european-congress-of-radiology-ecr-july-13-17-2022-vienna-austria-with-two-presentations-on-ibiopsy\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/median-technologies-to-participate-in-the-2022-european-congress-of-radiology-ecr-july-13-17-2022-vienna-austria-with-two-presentations-on-ibiopsy\\\/\",\"name\":\"Median Technologies to Participate in the 2022 European Congress of Radiology (ECR), July 13 \u2013 17, 2022, Vienna, Austria, with Two Presentations on iBiopsy\u00ae - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/median-technologies-to-participate-in-the-2022-european-congress-of-radiology-ecr-july-13-17-2022-vienna-austria-with-two-presentations-on-ibiopsy\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/median-technologies-to-participate-in-the-2022-european-congress-of-radiology-ecr-july-13-17-2022-vienna-austria-with-two-presentations-on-ibiopsy\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220708005258\\\/en\\\/1343975\\\/21\\\/Median_RGB.jpg\",\"datePublished\":\"2022-07-08T16:01:32+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/median-technologies-to-participate-in-the-2022-european-congress-of-radiology-ecr-july-13-17-2022-vienna-austria-with-two-presentations-on-ibiopsy\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/median-technologies-to-participate-in-the-2022-european-congress-of-radiology-ecr-july-13-17-2022-vienna-austria-with-two-presentations-on-ibiopsy\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/median-technologies-to-participate-in-the-2022-european-congress-of-radiology-ecr-july-13-17-2022-vienna-austria-with-two-presentations-on-ibiopsy\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220708005258\\\/en\\\/1343975\\\/21\\\/Median_RGB.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220708005258\\\/en\\\/1343975\\\/21\\\/Median_RGB.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/median-technologies-to-participate-in-the-2022-european-congress-of-radiology-ecr-july-13-17-2022-vienna-austria-with-two-presentations-on-ibiopsy\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Median Technologies to Participate in the 2022 European Congress of Radiology (ECR), July 13 \u2013 17, 2022, Vienna, Austria, with Two Presentations on iBiopsy\u00ae\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Median Technologies to Participate in the 2022 European Congress of Radiology (ECR), July 13 \u2013 17, 2022, Vienna, Austria, with Two Presentations on iBiopsy\u00ae - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/median-technologies-to-participate-in-the-2022-european-congress-of-radiology-ecr-july-13-17-2022-vienna-austria-with-two-presentations-on-ibiopsy\/","og_locale":"en_US","og_type":"article","og_title":"Median Technologies to Participate in the 2022 European Congress of Radiology (ECR), July 13 \u2013 17, 2022, Vienna, Austria, with Two Presentations on iBiopsy\u00ae - Pharma Trend","og_description":"Industry presentation on July 13, 2022: \u201cEnabling lung cancer screening with iBiopsy\u00ae AI-based software as medical device\u201d Scientific paper presentation on July 15, 2022: \u201cDevelopment and validation of a machine learning based CADx designed to improve patient management in lung cancer screening programmes\u201d Median will present the latest developments on iBiopsy\u00ae LCS CADe\/CADx1 Software as ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/median-technologies-to-participate-in-the-2022-european-congress-of-radiology-ecr-july-13-17-2022-vienna-austria-with-two-presentations-on-ibiopsy\/","og_site_name":"Pharma Trend","article_published_time":"2022-07-08T16:01:32+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220708005258\/en\/1343975\/21\/Median_RGB.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/median-technologies-to-participate-in-the-2022-european-congress-of-radiology-ecr-july-13-17-2022-vienna-austria-with-two-presentations-on-ibiopsy\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/median-technologies-to-participate-in-the-2022-european-congress-of-radiology-ecr-july-13-17-2022-vienna-austria-with-two-presentations-on-ibiopsy\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Median Technologies to Participate in the 2022 European Congress of Radiology (ECR), July 13 \u2013 17, 2022, Vienna, Austria, with Two Presentations on iBiopsy\u00ae","datePublished":"2022-07-08T16:01:32+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/median-technologies-to-participate-in-the-2022-european-congress-of-radiology-ecr-july-13-17-2022-vienna-austria-with-two-presentations-on-ibiopsy\/"},"wordCount":666,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/median-technologies-to-participate-in-the-2022-european-congress-of-radiology-ecr-july-13-17-2022-vienna-austria-with-two-presentations-on-ibiopsy\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220708005258\/en\/1343975\/21\/Median_RGB.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/median-technologies-to-participate-in-the-2022-european-congress-of-radiology-ecr-july-13-17-2022-vienna-austria-with-two-presentations-on-ibiopsy\/","url":"https:\/\/pharma-trend.com\/en\/median-technologies-to-participate-in-the-2022-european-congress-of-radiology-ecr-july-13-17-2022-vienna-austria-with-two-presentations-on-ibiopsy\/","name":"Median Technologies to Participate in the 2022 European Congress of Radiology (ECR), July 13 \u2013 17, 2022, Vienna, Austria, with Two Presentations on iBiopsy\u00ae - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/median-technologies-to-participate-in-the-2022-european-congress-of-radiology-ecr-july-13-17-2022-vienna-austria-with-two-presentations-on-ibiopsy\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/median-technologies-to-participate-in-the-2022-european-congress-of-radiology-ecr-july-13-17-2022-vienna-austria-with-two-presentations-on-ibiopsy\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220708005258\/en\/1343975\/21\/Median_RGB.jpg","datePublished":"2022-07-08T16:01:32+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/median-technologies-to-participate-in-the-2022-european-congress-of-radiology-ecr-july-13-17-2022-vienna-austria-with-two-presentations-on-ibiopsy\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/median-technologies-to-participate-in-the-2022-european-congress-of-radiology-ecr-july-13-17-2022-vienna-austria-with-two-presentations-on-ibiopsy\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/median-technologies-to-participate-in-the-2022-european-congress-of-radiology-ecr-july-13-17-2022-vienna-austria-with-two-presentations-on-ibiopsy\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220708005258\/en\/1343975\/21\/Median_RGB.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220708005258\/en\/1343975\/21\/Median_RGB.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/median-technologies-to-participate-in-the-2022-european-congress-of-radiology-ecr-july-13-17-2022-vienna-austria-with-two-presentations-on-ibiopsy\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Median Technologies to Participate in the 2022 European Congress of Radiology (ECR), July 13 \u2013 17, 2022, Vienna, Austria, with Two Presentations on iBiopsy\u00ae"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/45989","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=45989"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/45989\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=45989"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=45989"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=45989"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}